Call (289) 812-0046
Clinical Trial
For adults (≥18) with moderate to severe hidradenitis suppurativa (subcutaneous study drug)
CLINICAL TRIAL
RECRUITING
Trial ID: NCT06444451
Phase 2 | Injection | 52 weeks
Phase 3 | Oral tablet | 164 weeks
Trial ID: NCT06012240
